Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-4641 in Relapsing-Remitting Multiple Sclerosis
NCT01081782Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Mar 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of ceralifimod in relapsing-remitting multiple sclerosis (RRMS), sponsored by Ono Pharmaceutical. Started Mar 2010; status: completed.
02
Drugs
ceralifimod
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01081782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01081782.